Plante Moran Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50
Closed -$3.45K 812
2024
Q1
$3.45K Buy
+50
New +$3.16K ﹤0.01% 719
2023
Q3
Sell
-10
Closed -$939 794
2023
Q2
$939 Sell
10
-80
-89% -$6.24K ﹤0.01% 733
2023
Q1
$6.1K Hold
90
﹤0.01% 628
2022
Q4
$4.46K Sell
90
-18
-17% -$735 ﹤0.01% 685
2022
Q3
$4K Buy
108
+18
+20% +$742 ﹤0.01% 726
2022
Q2
$4K Hold
90
﹤0.01% 736
2022
Q1
$6K Hold
90
﹤0.01% 651
2021
Q4
$7K Hold
90
﹤0.01% 751
2021
Q3
$9K Hold
90
﹤0.01% 705
2021
Q2
$11K Hold
90
﹤0.01% 662
2021
Q1
$12K Sell
90
-400
-82% -$54.8K ﹤0.01% 621
2020
Q4
$65K Buy
490
+400
+444% +$48.4K 0.02% 306
2020
Q3
$9K Hold
90
﹤0.01% 622
2020
Q2
$8K Hold
90
﹤0.01% 543
2020
Q1
$5K Hold
90
﹤0.01% 569
2019
Q4
$8K Buy
+90
New +$7.91K ﹤0.01% 564
2016
Q1
Sell
-18
Closed 907
2015
Q4
$0 Buy
+18
New +$167 ﹤0.01% 961

Other funds holding EXAS

Plante Moran Financial Advisors's EXAS Position: Q2 2024 in Review

Plante Moran Financial Advisors sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 50 shares — an estimated $3.45K sold.

Plante Moran Financial Advisors first reported a position in EXAS in Q4 2015 and held it in 17 quarters. The position peaked at $65K in Q4 2020. 544 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Plante Moran Financial Advisors reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 50 Exact Sciences shares in Q2 2024, an estimated $3.45K.
  • Plante Moran Financial Advisors first reported a position in Exact Sciences in Q4 2015 and held it in 17 quarters.
  • Plante Moran Financial Advisors's Exact Sciences position peaked at $65K in Q4 2020.
  • 544 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.